TY - JOUR
T1 - Prevalence of and risk factors for anal high-risk HPV among HIV-negative and HIV-positive MSM and transgender women in three countries at South-East Asia
AU - on behalf of the ANSAP Study Group
AU - Somia, I. Ketut Agus
AU - Teeratakulpisarn, Nipat
AU - Jeo, Wifanto S.
AU - Yee, Ilias A.
AU - Pankam, Tippawan
AU - Nonenoy, Siriporn
AU - Trachuntong, Deondara
AU - Mingkwanrungrueng, Pravit
AU - Sukmawati, Made Dewi D.
AU - Ramautarsing, Reshmie
AU - Nilasari, Hanny
AU - Hairunisa, Nany
AU - Azwa, Iskandar
AU - Yunihastuti, Evy
AU - Merati, Tuti P.
AU - Phanuphak, Praphan
AU - Palefsky, Joel
AU - Phanuphak, Nittaya
N1 - Funding Information:
This study was supported through a grant from TREAT Asia, a program of amfAR, The Foundation for AIDS Research, with support from the US National Institutes of Health’s National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and National Cancer Institute as part of the International Epidemiology Databases to Evaluate AIDS (IeDEA; U01AI069907), the Office of the Global AIDS Coordinator for the President’s Emergency Plan for AIDS Relief, and the AIDS LIFE Association.
Funding Information:
The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the governments or institutions. This study was supported through a grant from TREAT Asia. The authors declare no conflicts of interest.
Publisher Copyright:
© 2018 the Author(s). Published by Wolters Kluwer Health, Inc.
PY - 2018/3/1
Y1 - 2018/3/1
N2 - This study aimed to assess the prevalence of and associated risk factors for anal high-risk human papillomavirus (hr-HPV) infection among men who have sex with men (MSM) and transgender women (TGW) in Indonesia, Thailand, and Malaysia. This was baseline data from a prospective cohort study with clinic sites in Jakarta and Bali (Indonesia), Bangkok (Thailand), and Kuala Lumpur (Malaysia). MSM and TGW aged 18 years and older from Indonesia, Thailand, and Malaysia were enrolled. Demographic and behavioral characteristics were assessed, and anal samples were collected for HPV genotyping. Multivariate logistic regression models were used to assess risk factors for anal hr-HPV overall and among HIV-positive participants. A total of 392 participants were enrolled, and 48 were TGW. As many as 245 were HIV-positive, and 78.0% of the participants were on combination antiretroviral therapy (cART). Median CD4 count was 439 cells/mm3 and 68.2% had undetectable HIV-RNA. HIV-positive participants had significantly more hr-HPV compared to HIV-negative participants (76.6% vs 53.5%, P < .001). HPV-16 was the most common high-risk type (20%), whereas HPV-33, -39, and -58 were significantly more common among HIV-positive participants. HIV-positive participant significantly associated with anal hr-HPV infection compared with HIV-negative (OR: 2.87, 95% CI: 1.76-4.70, P ≤.001), whereas among HIV-positive participants transgender identity had lower prevalence of hr-HPV infection (OR: 0.42, 95% CI: 0.19-0.91, P = .03). High-risk HPV infection was very common among MSM and TGW in South-East Asia. Overall, HIV-infection, regardless of cART use and immune status, significantly increased the risk, while among HIV-positive participants transgender identity seemed to decrease the risk of anal hr-HPV.
AB - This study aimed to assess the prevalence of and associated risk factors for anal high-risk human papillomavirus (hr-HPV) infection among men who have sex with men (MSM) and transgender women (TGW) in Indonesia, Thailand, and Malaysia. This was baseline data from a prospective cohort study with clinic sites in Jakarta and Bali (Indonesia), Bangkok (Thailand), and Kuala Lumpur (Malaysia). MSM and TGW aged 18 years and older from Indonesia, Thailand, and Malaysia were enrolled. Demographic and behavioral characteristics were assessed, and anal samples were collected for HPV genotyping. Multivariate logistic regression models were used to assess risk factors for anal hr-HPV overall and among HIV-positive participants. A total of 392 participants were enrolled, and 48 were TGW. As many as 245 were HIV-positive, and 78.0% of the participants were on combination antiretroviral therapy (cART). Median CD4 count was 439 cells/mm3 and 68.2% had undetectable HIV-RNA. HIV-positive participants had significantly more hr-HPV compared to HIV-negative participants (76.6% vs 53.5%, P < .001). HPV-16 was the most common high-risk type (20%), whereas HPV-33, -39, and -58 were significantly more common among HIV-positive participants. HIV-positive participant significantly associated with anal hr-HPV infection compared with HIV-negative (OR: 2.87, 95% CI: 1.76-4.70, P ≤.001), whereas among HIV-positive participants transgender identity had lower prevalence of hr-HPV infection (OR: 0.42, 95% CI: 0.19-0.91, P = .03). High-risk HPV infection was very common among MSM and TGW in South-East Asia. Overall, HIV-infection, regardless of cART use and immune status, significantly increased the risk, while among HIV-positive participants transgender identity seemed to decrease the risk of anal hr-HPV.
KW - Anal high-risk HPV
KW - HIV-positive
KW - Indonesia
KW - MSM
KW - Malaysia
KW - Thailand
KW - transgender women
UR - http://www.scopus.com/inward/record.url?scp=85044026740&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000009898
DO - 10.1097/MD.0000000000009898
M3 - Article
C2 - 29517698
AN - SCOPUS:85044026740
SN - 0025-7974
VL - 97
JO - Medicine (United States)
JF - Medicine (United States)
IS - 10
M1 - e9898
ER -